PL1802340T3 - Połączenie rekombinowanej mycobacterium i biologicznie czynnego środka jako szczepionka - Google Patents
Połączenie rekombinowanej mycobacterium i biologicznie czynnego środka jako szczepionkaInfo
- Publication number
- PL1802340T3 PL1802340T3 PL05795016T PL05795016T PL1802340T3 PL 1802340 T3 PL1802340 T3 PL 1802340T3 PL 05795016 T PL05795016 T PL 05795016T PL 05795016 T PL05795016 T PL 05795016T PL 1802340 T3 PL1802340 T3 PL 1802340T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine
- combination
- active agent
- biologically active
- recombinant mycobacterium
- Prior art date
Links
- 241000186359 Mycobacterium Species 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04025096A EP1649869A1 (en) | 2004-10-21 | 2004-10-21 | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
| PCT/EP2005/011127 WO2006045468A1 (en) | 2004-10-21 | 2005-10-16 | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
| EP05795016.4A EP1802340B1 (en) | 2004-10-21 | 2005-10-16 | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1802340T3 true PL1802340T3 (pl) | 2015-03-31 |
Family
ID=35462399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05795016T PL1802340T3 (pl) | 2004-10-21 | 2005-10-16 | Połączenie rekombinowanej mycobacterium i biologicznie czynnego środka jako szczepionka |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9078844B2 (pl) |
| EP (2) | EP1649869A1 (pl) |
| JP (1) | JP4836957B2 (pl) |
| KR (1) | KR101300905B1 (pl) |
| CN (1) | CN101048178B (pl) |
| AU (1) | AU2005298976A1 (pl) |
| BR (1) | BRPI0517003B1 (pl) |
| CA (1) | CA2584321C (pl) |
| DK (1) | DK1802340T3 (pl) |
| ES (1) | ES2524921T3 (pl) |
| HK (1) | HK1106929A1 (pl) |
| MX (1) | MX2007004734A (pl) |
| PL (1) | PL1802340T3 (pl) |
| PT (1) | PT1802340E (pl) |
| RU (1) | RU2495677C2 (pl) |
| SI (1) | SI1802340T1 (pl) |
| UA (1) | UA101140C2 (pl) |
| WO (1) | WO2006045468A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007058663A2 (en) | 2004-12-01 | 2007-05-24 | Aeras Global Tb Vaccine Foundation | Recombinant bcg strains with enhanced ability to escape the endosome |
| CN101969976A (zh) | 2008-01-11 | 2011-02-09 | 美国政府健康与人类服务部秘书处 | 针对分枝杆菌的多肽疫苗和接种策略 |
| PL3360569T3 (pl) * | 2010-09-20 | 2020-07-27 | Vakzine Projekt Management Gmbh | Rekombinowane Mycobacterium jako szczepionka do stosowania u ludzi |
| SG191332A1 (en) * | 2010-12-21 | 2013-07-31 | Max Planck Gesellschaft | Recombinant mycobacterium as a vaccine |
| EP2757155B1 (en) * | 2011-09-13 | 2016-06-29 | Japan BCG Laboratory | Recombinant bcg vaccine |
| EP3090757A1 (en) * | 2015-05-04 | 2016-11-09 | Vakzine Projekt Management GmbH | Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer |
| WO2021202361A1 (en) * | 2020-03-30 | 2021-10-07 | North Carolina State University | Engineered bacteria for use in vaccine compositions |
| CN113499439B (zh) * | 2021-07-20 | 2023-03-17 | 上海市肺科医院 | 结核菌UreC蛋白在制备抗结核分枝杆菌药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU693435B2 (en) | 1993-02-17 | 1998-07-02 | Sloan-Kettering Institute For Cancer Research | Allogeneic vaccine and method to synthesize same |
| US20050169900A1 (en) * | 1993-02-17 | 2005-08-04 | Sloan Kettering Institute For Cancer Research | Allogeneic vaccine and methods to synthesize same |
| DE19640817A1 (de) * | 1996-10-02 | 1998-05-14 | Hermann Prof Dr Bujard | Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1 |
| EP0902086A1 (en) * | 1997-08-22 | 1999-03-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tuberculosis vaccine |
| DE19910044A1 (de) * | 1999-03-08 | 2000-09-14 | Bodo Plachter | Virale Partikel, die nach Infektion durch humanes Cytomegalovirus freigesetzt werden und ihre Verwendung als Impfstoff |
| AU3337300A (en) * | 1999-03-15 | 2000-10-04 | Agresearch Limited | Treatment of asthma |
| KR101101263B1 (ko) * | 2003-04-23 | 2012-01-04 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | 개선된 효능을 갖는 결핵 백신 |
| US7855268B2 (en) * | 2006-06-01 | 2010-12-21 | Allergan, Inc. | Tolerogizing compositions comprising botulinum toxin type B peptides |
| US7670788B2 (en) * | 2006-06-01 | 2010-03-02 | Allergan, Inc. | Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides |
-
2004
- 2004-10-21 EP EP04025096A patent/EP1649869A1/en not_active Withdrawn
-
2005
- 2005-10-16 WO PCT/EP2005/011127 patent/WO2006045468A1/en active Application Filing
- 2005-10-16 SI SI200531915T patent/SI1802340T1/sl unknown
- 2005-10-16 BR BRPI0517003-6A patent/BRPI0517003B1/pt active IP Right Grant
- 2005-10-16 CN CN2005800363269A patent/CN101048178B/zh active Active
- 2005-10-16 KR KR1020077009076A patent/KR101300905B1/ko active IP Right Grant
- 2005-10-16 US US11/577,498 patent/US9078844B2/en active Active
- 2005-10-16 AU AU2005298976A patent/AU2005298976A1/en not_active Abandoned
- 2005-10-16 RU RU2007118675/10A patent/RU2495677C2/ru active
- 2005-10-16 CA CA2584321A patent/CA2584321C/en active Active
- 2005-10-16 MX MX2007004734A patent/MX2007004734A/es active IP Right Grant
- 2005-10-16 PL PL05795016T patent/PL1802340T3/pl unknown
- 2005-10-16 ES ES05795016.4T patent/ES2524921T3/es active Active
- 2005-10-16 EP EP05795016.4A patent/EP1802340B1/en active Active
- 2005-10-16 UA UAA200704420A patent/UA101140C2/ru unknown
- 2005-10-16 PT PT57950164T patent/PT1802340E/pt unknown
- 2005-10-16 DK DK05795016.4T patent/DK1802340T3/en active
- 2005-10-16 JP JP2007537177A patent/JP4836957B2/ja active Active
-
2008
- 2008-01-18 HK HK08100658.5A patent/HK1106929A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1802340A1 (en) | 2007-07-04 |
| DK1802340T3 (en) | 2014-12-01 |
| KR20070068398A (ko) | 2007-06-29 |
| ES2524921T3 (es) | 2014-12-15 |
| CA2584321A1 (en) | 2006-05-04 |
| AU2005298976A1 (en) | 2006-05-04 |
| RU2495677C2 (ru) | 2013-10-20 |
| MX2007004734A (es) | 2007-07-13 |
| CA2584321C (en) | 2021-06-15 |
| WO2006045468A1 (en) | 2006-05-04 |
| HK1106929A1 (en) | 2008-03-20 |
| JP2008517013A (ja) | 2008-05-22 |
| US9078844B2 (en) | 2015-07-14 |
| KR101300905B1 (ko) | 2013-08-27 |
| US20080292656A1 (en) | 2008-11-27 |
| JP4836957B2 (ja) | 2011-12-14 |
| BRPI0517003B1 (pt) | 2021-10-13 |
| CN101048178A (zh) | 2007-10-03 |
| RU2007118675A (ru) | 2008-11-27 |
| EP1802340B1 (en) | 2014-09-03 |
| EP1649869A1 (en) | 2006-04-26 |
| UA101140C2 (ru) | 2013-03-11 |
| SI1802340T1 (sl) | 2015-01-30 |
| PT1802340E (pt) | 2014-12-09 |
| CN101048178B (zh) | 2012-09-05 |
| BRPI0517003A (pt) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1106929A1 (en) | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine | |
| EP1740197A4 (en) | THERAPEUTIC ENZYME FORMULATIONS AND THEIR USES | |
| EP1804823A4 (en) | NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS | |
| HK1112619A1 (en) | Cyclopamine analogues and methods of use thereof | |
| EP1711124A4 (en) | LONG-TERM RELEASE PREPARATIONS AND METHODS OF USE THEREOF | |
| EP1804831A4 (en) | VACCINES BASED ON LLO AND LISTERIA | |
| EP1781689A4 (en) | CONJUGATES AND THEIR THERAPEUTIC APPLICATIONS | |
| IL178894A0 (en) | Therapeutic antimicrobial compositions and methods | |
| ZA200703313B (en) | Recombinant human T2 RNase and uses thereof | |
| EP1838331A4 (en) | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | |
| EP1933863A4 (en) | PARATHYROIDIAN HORMONE ANALOGS AND METHODS USING SAME | |
| EP1809656A4 (en) | CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS | |
| EP1758605A4 (en) | PROUROGUANYLIN AS THERAPEUTIC AND DIAGNOSTIC AGENTS | |
| GB0619979D0 (en) | Novel hydroxamates as therapeutic agents | |
| EP1814393A4 (en) | TOLEROGENIC VACCINE AND METHOD THEREOF | |
| EP1812048A4 (en) | GH SECRETAGOGA AND ITS USE | |
| GB0509749D0 (en) | A method of delivering a biologically active agent | |
| IL181300A (en) | Formulations of light-sensitive materials and their use | |
| EP1789065A4 (en) | BIOLOGICALLY ACTIVE COMPOSITION | |
| EP1830805A4 (en) | COMPOSITIONS OF POLYMER EMULSIFICATORS AND METHOD OF USE | |
| ZA200705844B (en) | Detoxifying and immunity-booster composition | |
| EP1765403A4 (en) | COMBINED ACTIVE AND PASSIVE TARGETING OF BIOLOGICALLY ACTIVE ACTIVE SUBSTANCES | |
| GB0411432D0 (en) | Biologically and therapeutically active agents | |
| GB0410772D0 (en) | Biologically and therapeuticaly active agents | |
| IL185548A0 (en) | Medical uses of 39-desmethoxyrapamycin and analogues thereof |